Revisions of 'Cardiac amyloidosis - ATTR'
-
Revision 4 - created over 1 year ago by Henry Knipe - view changesetDate: 2022-10-26 06:50:41 UTC Disclosures:
At the time the revision was created Henry Knipe had the following disclosures:
- Radiopaedia Events Pty Ltd, Speaker fees (past)
- Integral Diagnostics, Shareholder (ongoing)
- Micro-X Ltd, Shareholder (ongoing)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Henry Knipe's current disclosures Reviewed by: Yuranga Weerakkody -
Revision 3 - created over 1 year ago by Bálint Botz - view changesetDate: 2022-09-25 18:06:26 UTC Disclosures:
At the time the revision was created Bálint Botz had no financial relationships to ineligible companies to disclose.
View Bálint Botz's current disclosures Reviewed by: Yahya Baba -
Revision 2 - created over 1 year ago by Joshua Yap - view changesetDate: 2022-07-15 07:37:07 UTC Disclosures:
At the time the revision was created Joshua Yap had no financial relationships to ineligible companies to disclose.
View Joshua Yap's current disclosures Reviewed by: Joachim Feger -
Revision 1 - created over 1 year ago by Sally Ayesa - view changesetDate: 2022-07-14 21:41:14 UTC Disclosures:
At the time the revision was created Sally Ayesa had no financial relationships to ineligible companies to disclose.
View Sally Ayesa's current disclosures Reviewed by: Joshua Yap
Unfortunately some older revisions may not be able to be viewed or restored.
Radiopaedia.org is a collaborative effort and anyone can contribute. Every revision counts. Learn more about contributing.
Each article also undergoes a sophisticated editorial process to ensure the high quality of Radiopaedia.org. Through open contributions by many different medical professionals, editorial oversight from our excellent editorial and expert review boards, and continual moderation, we can continue to provide the best, free radiology resource online.